23/10/2026 - Campus Can Ruti, Research

HIPRA's COVID-19 vaccine generates a broad and long-lasting immune response to SARS-CoV-2 in adolescents, as demonstrated in adults

A clinical trial involving 240 adolescents aged 12 to 17 has shown that HIPRA's COVID-19 vaccine, BIMERVAX®, administered as a booster dose, induces a broad immune response against different SARS-CoV-2 variants, comparable to that observed in adults and sustained for at least one year. The study, published in Pediatrics, was led by IrsiCaixa, IGTP, VHIR and HIPRA as part of the European RBDCOV project.

21/10/2026 - Projects, Research

Air pollution and temperature variability are associated with higher blood glucose levels

A European study involving GCAT-IGTP has identified an association between greater exposure to air pollution, particularly PM10 particles, greater temperature variability and higher blood glucose levels in people without diabetes. The findings highlight the importance of studying environmental factors together and improving air quality in the context of climate change.

20/10/2026 - Campus Can Ruti, Conferences, Institutional

Artificial intelligence and biomarkers take centre stage at a new IGTP-EATRIS event

IGTP held a new event in collaboration with EATRIS, the European infrastructure for translational medicine, focusing this year on the role of artificial intelligence in biomarker research and precision medicine.

16/10/2026 - Campus Can Ruti, Innovation

Innomed visits IDNEO to learn about its capabilities in device development and digital technologies

The Innomed community visited IDNEO to learn about its capabilities in device development, digital technologies and MedTech solutions. The visit aimed to identify opportunities for collaboration between research teams and industry to advance healthcare innovation projects.

15/10/2026 - Innovation, Research, Success Stories

IGTP project receives €49,000 from CaixaImpulse to advance a precision cell therapy for multiple sclerosis

A project led by Federico Fondelli, researcher at the IGTP, has been selected in the 2026 CaixaImpulse Health Innovation call promoted by the "la Caixa" Foundation. The project will receive €49,000 to advance the development of a new cell therapy strategy aimed at specifically restoring the immune system's tolerance to myelin in people with multiple sclerosis.

14/10/2026 - Research, Success Stories

The CMCiB expands its housing capacity and upgrades infrastructure for biomedical research

The CMCiB, strategic project of IGTP, continues to strengthen its capacity to support biomedical research with the opening of a new rodent housing facility and the upgrading of part of its animal housing systems. This initiative increases the centre's capacity to support researchers, strengthens safety and biocontainment, improves animal welfare and provides more efficient working environments for health research projects.

09/10/2026 - Campus Can Ruti, Outreach, Success Stories

Mental health, stigma and new models of psychiatric care in the latest episode of ‘Un bri de ciència’

To mark World Mental Health Day, the IGTP and HUGTiP podcast 'Un bri de ciència' releases its twelfth episode, featuring psychiatrist Jorge Cuevas. The conversation explores mental health, stigma and the importance of professional support, alongside research at Germans Trias into new models of psychiatric care.

08/10/2026 - Campus Can Ruti, Conferences, Innovation, Institutional

IGTP explores new opportunities for collaboration with Türkiye's research and innovation ecosystem

IGTP welcomed a delegation of research organisations, universities and innovation stakeholders from Türkiye as part of a health-focused technical mission to Spain. The visit provided an opportunity to share expertise, explore potential collaborations and strengthen connections for future European research projects.

30/09/2026 - Research

GCAT joins OMega-X, a European consortium studying the impact of working life on health

An article published in the International Journal of Epidemiology presents this European resource, which brings together 24 cohorts from eight countries and multinational studies, with data from more than 20 million participants.

23/09/2026 - Campus Can Ruti, Innovation, Projects

The Germans Trias Glaucoma Unit becomes the first in Catalonia to achieve accreditation for excellence in managing this highly complex condition

The Germans Trias Glaucoma Unit has become the first in Catalonia to achieve the highest level of GlauCCare accreditation, recognising its excellence in the care of people with glaucoma. Alongside specialised care, the unit collaborates with the Germans Trias i Pujol Research Institute (IGTP) on research and innovation projects aimed at improving the diagnosis and treatment of the disease.